Also from this source

You just read:

FDA Accepts Supplemental New Drug Application For Tarceva® (erlotinib) Tablets For Genetically Distinct Form Of Advanced Lung Cancer

News provided by

Astellas Pharma US, Inc.

Jan 16, 2013, 08:00 EST